loading...| Preferred Name |
candesartan cilexetil |
|
| Synonyms |
1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate |
|
| ID |
http://purl.bioontology.org/ontology/MESH/C077793 |
|
| altLabel |
1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate 1H-benzimidazolium, 7-carboxy-1-(2-((cyclohexylcarbonyl)oxy)ethyl)-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)-, hydroxide, inner salt, (+-)- Kenzen Parapres Amias TCV 116 Atacand Blopress TCV-116 |
|
| cui |
C4310340 C0174494 C0527379 C4083053 C1529675 C0718711 C4083054 |
|
| HM |
D013777 D001713 D001562 |
|
| Inverse of RB |
R85M2X0D68 |
|
| isa | ||
| LT |
TRD |
|
| Mapped to |
http://purl.bioontology.org/ontology/MESH/D001713 |
|
| MDA |
19921203 |
|
| MeSH Frequency |
609 |
|
| MMR |
20210218 |
|
| notation |
C077793 |
|
| PA |
D000959 D047228 |
|
| prefLabel |
candesartan cilexetil |
|
| RR |
145040-37-5 (candesartan cilexetil) |
|
| SC |
1 |
|
| Scope Statement |
a prodrug which is metabolized to an active form candesartan to exert its biological effects |
|
| SRC |
Life Sci 1992;51(20):PL-183-7 |
|
| TERMUI |
T461822 T622397 T238745 T238747 T001097708 T238746 T238744 T534906 T622398 T622395 |
|
| TH |
US MX UK NL CA FDA SRS (2013) ES NLM (1992) NLM (2021) USAN (19XX) DE AU USP (19XX) FR IE |
|
| tui |
T109 T121 |